Metagenomi, Inc.
MGX
$2.03
-$0.045-2.17%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -18.77M | -10.74M | -25.15M | -19.29M | -19.82M |
| Total Depreciation and Amortization | 1.36M | 1.31M | 1.27M | 1.20M | 1.15M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 3.33M | 3.87M | 4.94M | 1.88M | 1.88M |
| Change in Net Operating Assets | -12.55M | -20.75M | -10.91M | -4.37M | -6.94M |
| Cash from Operations | -26.64M | -26.31M | -29.85M | -20.59M | -23.73M |
| Capital Expenditure | -1.20M | -665.00K | -915.00K | -1.74M | -2.26M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -7.73M | -12.37M | -93.82M | 62.37M | 78.15M |
| Cash from Investing | -8.93M | -13.04M | -94.73M | 60.63M | 75.89M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | 86.54M | -- | -- |
| Repurchase of Common Stock | -492.00K | -2.03M | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | 0.00 | 0.00 |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -1.33M | -1.91M |
| Cash from Financing | -492.00K | -2.03M | 86.54M | -1.33M | -1.91M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -36.06M | -41.38M | -38.05M | 38.71M | 50.25M |
